603976 Chongqing Zhengchuan Pharmaceutical Packaging
- 15.93
- +0.53+3.44%
Chongqing Zhengchuan Pharmaceutical Packaging News
Zhengchuan Co., Ltd. (603976.SH): The company is actively expanding the market for high-end products such as pre-filled syringe assemblies, cartridges, and disposable injector bottles. Currently, it is still in the market development stage
Gelonghui, May 8, 丨 Zhenchuan Co., Ltd. (603976.SH) Investor Relations Activity Record Sheet shows that the company is actively expanding the market for high-end products such as pre-filled syringe assemblies, cartridges, and disposable injection bottles, and is currently still in the market development stage. According to market demand and the actual situation of market development, production capacity will be gradually released, and efforts will be made to form new profit growth points through new products.
Zhengchuan Co., Ltd. (603976.SH): The current trend of medium boron replacing low shelf products is still quite obvious
Gelonghui, May 8 | Zhengchuan Co., Ltd. (603976.SH) Investor Relations Activity Record Sheet shows that the current trend of boron replacing low-shelf products with medium boron is still quite obvious, and the share of boron in individual markets is gradually increasing. There is a clear trend of localization in the borosilicate control bottle market. With the improvement in the quality of domestic control bottles and the price advantage compared to imported ones, the localization rate of borosilicate control bottles is expected to increase further.
Zhengchuan Co., Ltd. (603976.SH): Net profit decreased by 37.83% in 2023 to 40.267,700 yuan, and plans to pay 2 yuan
On April 26, Ge Longhui Co., Ltd. (603976.SH) released its 2023 annual report, achieving operating income of 901 million yuan, an increase of 13.12%; net profit attributable to shareholders of listed companies of 40.267,700 yuan, a year-on-year decrease of 37.83%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss of 298.623 million yuan, a year-on-year decrease of 48.23%; and basic earnings per share of 0.27 yuan. It is proposed to distribute a cash dividend of 2 yuan (tax included) for every 10 shares to all shareholders.
Zhengchuan Co., Ltd. (603976.SH): Net profit of 21.4476 million yuan in the first quarter increased 61.97% year-on-year
On April 26, Ge Longhui Co., Ltd. (603976.SH) released its report for the first quarter of 2024, achieving operating income of 246 million yuan, an increase of 8.94%; net profit attributable to shareholders of listed companies of 20.0476 million yuan, an increase of 61.97% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss of 20.3823 million yuan, an increase of 88.37% year on year; basic earnings per share of 0.14 yuan.
ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd's (SHSE:603976) Stock Price Dropped 18% Last Week; Private Companies Would Not Be Happy
Key Insights Significant control over ChongQing Zhengchuan Pharmaceutical PackagingLtd by private companies implies that the general public has more power to influence management and governance-relate
Zhengchuan Co., Ltd. (603976): Ready to take advantage of borosilicate to replace Dongfeng control bottle faucets
Recommended logic: 1) Driven by generic drug consistency evaluation and related review policies, the upgrading and replacement of borosilicate is accelerated. Assuming that 50% penetration rate is reached by 2025, the replacement space for borosilicate control bottles and ampoules can reach 10 billion and 200
[BT Financial Report Instantaneous Analysis] Zhengchuan Co., Ltd. 2023 Q3 Report: Net profit declined, net cash flow increased sharply
This financial report was announced on 2023-10-25 16:20:02. Zhengchuan Co., Ltd. (stock code: 603976) is an enterprise focusing on the pharmaceutical packaging materials industry, mainly engaged in R&D, production and sales of pharmaceutical packaging materials such as pharmaceutical glass control bottles. The company has more than 30 years of development experience in the field of pharmaceutical glass and is one of the leading enterprises in the domestic pharmaceutical glass control bottle segment. According to the company's 2023 three-quarter report, the company's total assets were 2,081 billion yuan, up 3.64% from 2,008 billion yuan at the end of the previous year. Total liabilities were $870 million, compared to
Zhengchuan Co., Ltd. (603976.SH): Net profit for the third quarter was 5.148,800 yuan, up 177.98% year on year
Glonghui, Oct. 25, 丨 Zhengchuan Co., Ltd. (603976.SH) announced its report for the third quarter of 2023. Revenue for the reporting period was 220 million yuan, up 22.34% year on year; net profit attributable to shareholders of listed companies was 5.148,800 yuan, up 177.98% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 4,416,600 yuan, up 278.03% year on year; basic earnings per share were 0.03 yuan/share.
Zhengchuan Co., Ltd. (603976.SH): Up to now, it has more than 700 cooperative customers
GLONGHUI, September 13丨Zhengchuan Co., Ltd. (603976.SH) said on the investor interactive platform that the company's sales and service network has covered the whole country. Up to now, it has more than 700 cooperative customers, including Sinopharm Group, Guangzhou Pharmaceutical Group, China Resources Pharmaceutical Group, Fosun Pharmaceutical Group, Yangzijiang Pharmaceutical Group, Yunnan Baiyao Group, and Infinitus.
Zhengchuan Co., Ltd. (603976.SH): Major domestic competitors include SCHOTT, Linoteglass and other companies
GLONGHUI September 8 丨 Some investors asked Zhengchuan Co., Ltd. (603976.SH): Hello, what are the main domestic competitors of your company's borosilicate pharmaceutical glass? What are your company's competitive advantages? Thank you, Zhengchuan Co., Ltd., for your reply: Hello, the company is one of the leading enterprises in the pharmaceutical glass control bottle segment in China. The main domestic competitors include SCHOTT, Linotebo and other companies. Please check the company's disclosed regular reports on its core competitiveness. Thank you for your interest in the company.
Zhengchuan Co., Ltd. (603976.SH): The market capacity of borosilicate pharmaceutical glass bottles in China is expected to increase further in 2023 and 2024
GLONGHUI September 8 | An investor asked Zhengchuan Co., Ltd. (603976.SH) a question: Hello, please predict the market capacity of borosilicate pharmaceutical glass bottles in China in 2023 and 2024. Zhengchuan Co., Ltd. replied: Hello, driven by national policies and industry, it is expected that the market capacity of borosilicate medicinal glass bottles in China will increase further in 2023 and 2024. Thank you for your interest!
Zhengchuan Co., Ltd. (603976.SH): The production capacity of borosilicate pharmaceutical glass ranks among the highest in the industry
GLONGHUI September 8 | An investor asked Zhengchuan Co., Ltd. (603976.SH) a question: Please ask your company to briefly introduce the domestic borosilicate pharmaceutical glass tube market situation and competitive pattern. What is your current production capacity for medium borosilicate pharmaceutical glass tubes? What is the market share? What is the production capacity of medium borosilicate medicinal glass bottles? What is the market share? Thank you, Zhengchuan Co., Ltd., for your reply: Hello, the borosilicate pharmaceutical glass tube market is currently fiercely competitive. Many other companies from outside the industry have entered the market, leading to an expansion in production capacity and increased competition in the industry. The company currently has two borosilicate pharmaceutical glass tube kilns. The production capacity of medium borosilicate pharmaceutical glass ranks among the highest in the industry. For specific business conditions, please follow the company's disclosure
Zhengchuan Co., Ltd. (603976.SH): Further increasing the company's scale and market share in the pharmaceutical glass field
GLONGHUI September 8 丨 Some investors asked Zhengchuan Co., Ltd. (603976.SH): With the advancement of national policies, there is a clear trend of transformation from low borosilicate pharmaceutical glass to medium borosilicate pharmaceutical glass. How can the company respond? Zhengchuan Co., Ltd. replied: Hello, the company is actively speeding up the expansion of production capacity and technological upgrading, and speeding up the upgrading of the company's business files. The company has always adhered to the strategic policy of expanding and strengthening the development of medicinal glass, actively developing the pharmaceutical glass packaging industry, and increasing the expansion and upgrading of high-end packaging products such as borosilicate glass; in recent years, the company has focused on increasing the maintenance of medium borosilicate pharmaceutical glass control bottles and medium borosilicate pharmaceutical glass tube tubing projects
Zhengchuan Co., Ltd. (603976.SH): The company's pre-filled syringe project infrastructure and equipment are all in place and commissioning has been completed
GLONGHUI September 8 丨 An investor asked Zhengchuan Co., Ltd. (603976.SH): Hello, is the equipment for your company's pre-filled products in place? Is it officially in production? Hello, is your company's equipment for pre-filling products in place? Is it officially in production? Zheng Chuan Co., Ltd. replied: Hello! The infrastructure and equipment for the company's pre-filled syringe project are all in place and commissioning has been completed. Currently, it is in the trial production stage. Thank you for your interest in the company!
Zhengchuan Co., Ltd. (603976.SH): The company's integrated advantages of “self-produced medium boron glass tubes - medium boron bottles” have been fully highlighted
GLONGHUI September 8 丨 An investor asked Zhengchuan Co., Ltd. (603976.SH): Hello, I would like to know about your company's technical research and development reserves on borosilicate pharmaceutical glass. Thank you. Zhengchuan Co., Ltd. replied: Hello, by introducing advanced equipment and technology from abroad and carrying out independent upgrades, the company has achieved stable mass production of medium boron glass tubes, which has been highly recognized by customers. At the same time, the company independently innovates the boron bottling process to promote the continuous maintenance of boron bottling technology at the leading level in the industry. The company's integrated advantages of “self-produced medium boron glass tubes - medium boron bottles” have been fully highlighted. Thank you for your interest!
Zhengchuan Co., Ltd. (603976.SH): Currently, the company's orders are relatively sufficient
GLONGHUI September 8 丨 Some investors asked Zhengchuan Co., Ltd. (603976.SH): How is the company's order status? Zhengchuan Co., Ltd. replied: Hello, the company's orders are currently relatively sufficient. For specific business conditions, please pay attention to the regular reports and related announcements disclosed by the company. The company will continue to do a solid job in production and operation and enhance its intrinsic value, continuously improve the company's management capabilities, promote the company's long-term healthy development, and create value for investors. Thank you for your interest!
Zhengchuan Co., Ltd. (603976.SH) released half-year results, net profit of 30.56 million yuan, down 24.58% year on year
Zhengchuan Co., Ltd. (603976.SH) disclosed the 2023 semi-annual report. The company achieved revenue of 4.48 during the reporting period...
Zhengchuan Co., Ltd. (603976.SH): It plans to raise no more than 60 million yuan for cash management
On June 30, GLONGHUI | Zhengchuan Co., Ltd. (603976.SH) announced that the company and subsidiaries intend to use no more than RMB 60 million in raised funds for cash management. The above funding amounts can be used on a rolling basis within 12 months from the date of review and approval by the board of directors.
The registration date for Zhengchuan Co., Ltd. (603976.SH) to distribute 0.6 yuan of shares for every 10 shares in 2022 is June 20
According to the Zhitong Finance App, Zhengchuan Co., Ltd. (603976.SH) announced that the company will implement the 2022 annual equity distribution, with a cash dividend of 0.06 yuan (tax included) per share. The equity registration date is June 20.
Zhengchuan Co., Ltd. (603976.SH) announced 2022 results, net profit of 64.765 million yuan, a year-on-year decrease of 39.25% and plans to distribute 0.6 yuan for every 10 shares
According to the Zhitong Finance App, Zhengchuan Co., Ltd. (603976.SH) released its 2022 annual report, with operating income of 796 million yuan, down 0.06% from the previous year; net profit attributable to shareholders of listed companies was 64.765 million yuan, down 39.25% from the previous year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 57.679 million yuan, down 37.61% from the previous year; basic earnings per share were 0.43 yuan, with a proposed cash dividend of 0.60 yuan (tax included) for every 10 shares.
Analysis
Price Target
No Data
